Related Experiment Video
Updated: Jun 6, 2026

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation
Published on: May 3, 2024
Plasma - Activated medium engages redox signaling to activate a VDAC1-TRPML1 lysosomal-mitochondrial Ca2+ death
Pengpeng Huang1, Yan Zheng2, Chuanzan Zhou3
1School of Nuclear Science and Technology, University of Science and Technology of China, Hefei, Anhui, China; Institute of Advanced Technology, University of Science and Technology of China, Hefei, Anhui, China.
Abstract:
Plasma-activated medium (PAM), a redox-active anticancer modality, induces cytotoxicity in multiple tumor models, but the mechanisms underlying PAM-induced tumor cell death remain incompletely understood. Here, using A549 lung cancer cells together with additional tumor models, we identify a lysosome - mitochondria Ca2+ circuit that drives a distinct form of PAM-induced tumor-selective cell death. PAM promotes the coupling of the lysosomal Ca2+ channel TRPML1 to the mitochondrial outer membrane protein VDAC1 at organelle contact sites, leading to lysosomal Ca2+ release, mitochondrial Ca2+ overload, membrane depolarization, cytochrome c release, and cell death. Mechanistically, PAM suppresses mTORC2 - SGK1 signaling, reduces VDAC1 phosphorylation at Ser104, and stabilizes VDAC1 on mitochondria. Accumulated VDAC1 then engages TRPML1 through Lys109 and Arg163 to facilitate pathological Ca2+ transfer. Disrupting this interface, or restoring phosphomimetic control of VDAC1, attenuated mitochondrial Ca2+ overload, improved cell survival, and weakened the antitumor effect of PAM in vivo. Pan-cancer analyses further suggested that although high VDAC1 expression is associated with poor prognosis, it may help stratify tumors more likely to respond to PAM. Together, these findings establish the VDAC1 - TRPML1 axis as a key mechanistic link between PAM-induced redox stress and lysosome - mitochondria Ca2+-dependent tumor cell death, and highlight this pathway as a potential therapeutic target and response biomarker.
Insights
Plasma-activated medium (PAM) triggers cancer cell death by disrupting calcium flow between lysosomes and mitochondria. This involves the VDAC1-TRPML1 axis, offering a potential therapeutic target and biomarker for cancer treatment.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Plasma-activated medium (PAM) is a redox-based anticancer therapy with unclear mechanisms of tumor cell death.
- Understanding PAM's action is crucial for optimizing its therapeutic potential.
Purpose of the Study:
- To elucidate the molecular mechanisms of PAM-induced tumor cell death.
- To identify key molecular players and pathways involved in PAM cytotoxicity.
- To explore the VDAC1-TRPML1 axis as a potential therapeutic target and biomarker.
Main Methods:
- Utilized A549 lung cancer cells and other tumor models.
- Investigated organelle contact sites and calcium (Ca2+) flux between lysosomes and mitochondria.
- Analyzed signaling pathways including mTORC2-SGK1 and VDAC1 phosphorylation.
- Performed in vivo studies and pan-cancer analyses.
Main Results:
- Identified a lysosome-mitochondria Ca2+ circuit critical for PAM-induced cell death.
- PAM promotes VDAC1-TRPML1 coupling, leading to lysosomal Ca2+ release and mitochondrial Ca2+ overload.
- PAM suppresses mTORC2-SGK1 signaling, stabilizing VDAC1 and enhancing pathological Ca2+ transfer.
- Disrupting the VDAC1-TRPML1 interaction or VDAC1 phosphorylation attenuated PAM's antitumor effects.
- High VDAC1 expression may predict tumor response to PAM.
Conclusions:
- The VDAC1-TRPML1 axis is a key mediator of PAM-induced, lysosome-mitochondria Ca2+-dependent tumor cell death.
- This pathway represents a novel therapeutic target and a potential biomarker for stratifying tumors for PAM therapy.
- Findings advance the understanding of redox-based cancer therapies and cell death mechanisms.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Apoptosis
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
